Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

Evidence-based pharmacotherapy of schizophrenia

(2011) Stefan Leucht et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Differential 3-Year Effects of First- Versus Second-Generation Antipsychotics on Subjective Well-Being in Schizophrenia Using Marginal Structural Models

(2011) Martin Lambert et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials

(2011) Claudia Leucht et al.   SCHIZOPHRENIA RESEARCH

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia

(2010) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine

(2010) Benedicto Crespo-Facorro et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

(2010) Christine Rummel-Kluge et al.   SCHIZOPHRENIA RESEARCH

Antipsychotic drugs and obesity

(2010) Christoph U. Correll et al.   TRENDS IN MOLECULAR MEDICINE

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-Term Efficacy and Safety of Iloperidone

(2008) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Pharmacotherapy of first-episode schizophrenia

(2008) Robert A Rosenheck   LANCET

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Second-Generation Antipsychotics: Cost-Effectiveness, Policy Options, and Political Decision Making

(2008) R. A. Rosenheck et al.   PSYCHIATRIC SERVICES